Can Fite BioPharma Ltd (CANF)
AMEX
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
ILS (ILS) | ILS (ILS) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -49.217 | -52.069 | -86.239 | -156.579 | -171.306 | -102.129 | -68.885 | -79.224 |
Return on Equity (%) | -95.31 | -135.358 | -224.41 | -462.708 | -355.989 | -148.661 | -107.913 | -142.492 |
Return on Invested Capital (%) | -119.835 | -214.808 | -216.77 | -528.593 | -371.883 | -125.557 | -107.097 | -152.963 |
Operating Margin (%) | -4109.202 | -543.495 | -160.733 | -600.295 | -1845.347 | -1478.429 | -1255.926 | -1027.456 |
Net Profit Margin (%) | -4069.325 | -588.181 | -172.016 | -621.309 | -1986.632 | -1782.532 | -1255.926 | -1027.456 |
Book Value Per Share | 0.529 | 0.319 | 0.075 | 0.02 | 0.013 | 0.018 | 0.005 | 0.005 |
Earnings Per Share | -0.942 | -0.519 | -0.163 | -0.105 | -0.033 | -0.019 | -0.012 | -0.006 |
Cash Per Share | 1.108 | 0.365 | 0.089 | 0.022 | 0.018 | 0.005 | 0.004 | 0.003 |
Working Capital Per Share | 1.038 | 0.529 | 0.118 | 0.032 | 0.018 | 0.021 | 0.008 | 0.006 |
Operating Profit Per Share | 0.023 | 0.144 | 0.095 | 0.017 | 0.002 | 0.001 | 0.001 | 0.001 |
EBIT Per Share | -0.955 | -0.517 | -0.163 | -0.105 | -0.031 | -0.015 | -0.012 | -0.006 |
EBITDA Per Share | -0.955 | -0.517 | -0.163 | -0.105 | -0.031 | -0.015 | -0.012 | -0.006 |
Free Cash Flow Per Share | -0.943 | -0.52 | -0.162 | -0.105 | -0.033 | -0.019 | -0.012 | -0.006 |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Year End December 30 2023 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|---|---|---|
ILS (ILS) | ILS (ILS) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | -1156.098 | N/A | N/A | N/A | -1301.02 | N/A | N/A | N/A |
Net Profit Margin (%) | -1187.317 | N/A | N/A | N/A | -1301.02 | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 11.75M |
Price to Earnings Ratio | 0 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 0 |
Dividend Yield | - |
Shares Outstanding | 5.57M |
Average Volume (1 week) | 61.42k |
Average Volume (1 Month) | 87.57k |
52 Week Change | 15.91% |
52 Week High | 4.69 |
52 Week Low | 1.83 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.